PHARMACOKINETICS OF AMILORIDE IN RENAL AND HEPATIC-DISEASE

被引：32
|
作者：
SPAHN, H
REUTER, K
MUTSCHLER, E
GEROK, W
KNAUF, H
机构：
[1] UNIV FRANKFURT,DEPT PHARMACOL,D-6000 FRANKFURT,FED REP GER
[2] UNIV FREIBURG,DEPT MED,D-7800 FREIBURG,FED REP GER
来源：
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1987年 / 33卷 / 05期
关键词：
D O I：
10.1007/BF00544242
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：493 / 498
页数：6
相关论文
共 50 条
  • [1] PHARMACOKINETICS OF ESMOLOL IN HEPATIC-DISEASE
    BUCHI, KN
    ROLLINS, DE
    TOLMAN, KG
    ACHARI, R
    DRISSEL, D
    HULSE, JD
    JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 27 (11) : 880 - 884
  • [2] PHARMACOKINETICS OF NICARDIPINE IN HEPATIC-DISEASE
    SALAZAR, TA
    CHANG, MM
    WRIGHT, T
    BOYER, T
    GAMBERTOGLIO, JG
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 47 (02) : 155 - 155
  • [3] PHARMACOKINETICS OF ISOXICAM IN HEPATIC-DISEASE
    FERRY, N
    CUISINAUD, G
    OUZAN, D
    TREPO, C
    SASSARD, J
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 22 : S143 - S147
  • [4] HEPATIC-DISEASE AND DRUG PHARMACOKINETICS
    WILLIAMS, RL
    MAMELOK, RD
    CLINICAL PHARMACOKINETICS, 1980, 5 (06) : 528 - 547
  • [5] PHARMACOKINETICS OF ESMOLOL IN HEPATIC-DISEASE
    ROLLINS, D
    BUCHI, K
    TOLMAN, K
    ACHARI, R
    DRISSEL, D
    HULSE, JD
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 39 (02) : 224 - 224
  • [6] PHARMACOKINETICS OF ESMOLOL IN HEPATIC-DISEASE
    BUCHI, KN
    ROLLINS, DE
    TOLMAN, KG
    ACHARI, R
    DRISSEL, D
    HULSE, JD
    CLINICAL RESEARCH, 1986, 34 (01): : A17 - A17
  • [7] EFFECT OF HUMAN RENAL AND HEPATIC-DISEASE ON THE PHARMACOKINETICS OF ANTICANCER DRUGS
    POWIS, G
    CANCER TREATMENT REVIEWS, 1982, 9 (02) : 85 - 124
  • [8] DRUG PHARMACOKINETICS IN CARDIAC AND HEPATIC-DISEASE
    WILLIAMS, RL
    BENET, LZ
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1980, 20 : 389 - 413
  • [9] PHARMACOKINETICS OF FAMCICLOVIR IN SUBJECTS WITH CHRONIC HEPATIC-DISEASE
    BOIKE, SC
    PUE, M
    AUDET, PR
    FREED, MI
    FAIRLESS, A
    ILSON, BE
    ZARIFFA, N
    JORKASKY, DK
    JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 34 (12) : 1199 - 1207
  • [10] THE EFFECTS OF RENAL AND HEPATIC-DISEASE ON THE PHARMACOKINETICS, RENAL TOLERANCE, AND RISK-BENEFIT PROFILE OF FLUOXETINE
    BERGSTROM, RF
    BEASLEY, CM
    LEVY, NB
    BLUMENFIELD, M
    LEMBERGER, L
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1993, 8 (04) : 261 - 266
12345